The net impact in autoimmune diseases is an imbalance where pro-inflammatory genes in T cells become epigenetically de-repressed (through DNA hypomethylation or open chromatin configuration), and regulatory genes (like FOXP3 or IL-2 in Tregs) may be inadequately expressed due to epigenetic silencing. This evidence concerns the gene IL2 and autoimmune disease.